Skip to main content
. 2026 Mar 27;13:1803929. doi: 10.3389/fmed.2026.1803929

TABLE 3.

Multivariate analysis of pCR after neoadjuvant immunotherapy for locally advanced MSS/pMMR colorectal cancer patients in the training cohort.

Variables OR (95%CI) P
Age (year) 0.96 (0.93 ∼ 0.99) 0.020
Post-LogCEA 0.19 (0.05 ∼ 0.70) 0.013
ΔGNRI 1.07 (1.02 ∼ 1.12) 0.006

OR, odds ratio; CI, confidence interval; Post-LogCEA, post–neoadjuvant treatment LogCEA. Bold values indicate P < 0.05, which is considered statistically significant.